They are not sharing the active enrollment # in the study. An update on that # would be nice. First patient was dosed around May 6th so that was 43 days ago. 238 Patients / 43 days is 5.5 Patients per day added to the trial. I would assume the # is fairly high but have nothing to support that with. AZ for example just reported over 2500 new cases today per CNBC a few minutes ago
Roivant may be further ahead with their pivotal BREATHE trial
May 13th they had an interim and disclosed 56 patients enrolled at that time ...more sites than HGEN including sites at Mt Sinai . They will enroll up to 270 patents vs 238 for HGEN ...but started earlier and may be enrolling faster .